Role of Orexin-B/Orexin 2 receptor in myocardial protection

Clinical Science - Tập 133 Số 7 - Trang 853-857 - 2019
Roberta Imperatore1,2, Luigia Cristino2
1Department of Science and Technology, University of Sannio, Benevento, Italy
2Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, Pozzuoli (NA), Italy

Tóm tắt

Abstract Emerging evidence attributes to orexins/hypocretins (ORs) a protective function in the regulation of cardiovascular responses, heart rate, and hypertension. However, little is known about any direct effect of orexins in the heart function. This is of special relevance considering that cardiovascular diseases, including myocardial infarction and heart failure, are one of the major causes of mortality in the world. In the article published in Clinical Science (2018) (vol. 132, 2547–2564), Patel and colleagues investigated the role of orexins in myocardial protection. Intriguingly, they revealed a source of orexin-A (OR-A) and orexin-B (OR-B) in the heart and cardiomyocytes of the rat. More interestingly, these peptides exert a direct effect on the heart rate by acting in an autocrine/paracrine manner on their respective receptors (OXRs). Indeed, OR-B, but not OR-A, by acting through orexin receptor-2 (OX2R), exerts direct cardioprotective effects in heart failure models. OR-B/OX2R signalling enhances myosin light chain (MLC) and troponin-I (TnI) phosphorylation in a dose-dependent manner, leading to an increase in the strength of their twitch contraction. This effect is mediated by extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation, both in the rat myocardial tissue and human heart samples. A negative correlation between OX2R expression and clinical severity of symptoms has been found in patients with heart failure. Thus, in addition to the known central effects of orexins/OX2R, the work of Patel and colleagues (Clinical Science (2018) 132, 2547–2564) reports a direct action of OR-B on the heart rate pinpointing to OX2R as a potential therapeutic target for prevention and treatment of cardiovascular disease.

Từ khóa


Tài liệu tham khảo

de Lecea, 1998, The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc. Natl. Acad. Sci. U.S.A., 95, 322, 10.1073/pnas.95.1.322

Sakurai, 1998, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell, 92, 573, 10.1016/S0092-8674(00)80949-6

Smart, 1999, Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR, Br. J. Pharmacol., 128, 1, 10.1038/sj.bjp.0702780

Smart, 2000, The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors, Br. J. Pharmacol., 129, 1289, 10.1038/sj.bjp.0703257

Imperatore, 2007, Role of Orexin-A in hypertension and obesity, Curr. Hypertens. Rep., 19, 34, 10.1007/s11906-017-0729-y

Samson, 1999, Cardiovascular regulatory actions of the hypocretins in brain, Brain Res., 831, 248, 10.1016/S0006-8993(99)01457-2

Shirasaka, 1999, Sympathetic and cardiovascular actions of orexins in conscious rats, Am. J. Physiol., 277, R1780

Mozaffarian, 2015, Heart disease and stroke statistics-2015 update: a report from the American Heart Association, Circulation, 131, e29

Townsend, 2015, Cardiovascular disease in Europe 2015: epidemiological update, Eur. Heart J., 36, 2673, 10.1093/eurheartj/ehv428

Matsumura, 2001, Central orexin-A augments sympathoadrenal out flow in conscious rabbits, Hypertension, 37, 1382, 10.1161/01.HYP.37.6.1382

Huang, 2010, Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors, J. Pharmacol. Exp. Ther., 334, 522, 10.1124/jpet.110.167791

Date, 1999, Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems, Proc. Natl. Acad. Sci. U.S.A., 96, 748, 10.1073/pnas.96.2.748

Allen, 2002, Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone, Hypertension, 39, 275, 10.1161/hy0202.104272

Li, 2007, Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension, Hypertension, 49, 916, 10.1161/01.HYP.0000259666.99449.74

Shahid, 2011, Intrathecal orexin a increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex, Br. J. Pharmacol., 162, 961, 10.1111/j.1476-5381.2010.01102.x

Peyron, 1998, Neurons containing hypocretin (orexin) project to multiple neuronal systems, J. Neurosci., 18, 9996, 10.1523/JNEUROSCI.18-23-09996.1998

Shirasaka, 2002, Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions, Regul. Pept., 104, 91, 10.1016/S0167-0115(01)00352-4

Shahid, 2012, Orexin and central regulation of cardiorespiratory system, Vitam. Horm., 89, 159, 10.1016/B978-0-12-394623-2.00009-3

Shirasaka, 2003, Cardiovascular effects of leptin and orexins, Am. J. Physiol. Regul. Integr. Comp. Physiol., 284, R639, 10.1152/ajpregu.00359.2002

Marcus, 2001, Differential expression of orexin receptors 1 and 2 in the rat brain, J. Comp. Neurol., 435, 6, 10.1002/cne.1190

Hagan, 1999, Orexin A activates locus coeruleus cell firing and increases arousal in the rat, Proc. Natl. Acad. Sci. U.S.A., 96, 10911, 10.1073/pnas.96.19.10911

Horvath, 1999, Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system, J. Comp. Neurol., 415, 145, 10.1002/(SICI)1096-9861(19991213)415:2%3c145::AID-CNE1%3e3.0.CO;2-2

van den Pol, 2002, Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus, J. Physiol., 541, 169, 10.1113/jphysiol.2002.017426

Chen, 2008, Reinvestigation of the effect of orexin A on catecholamine release from adrenal chromaffin cells, Neurosci. Lett., 436, 181, 10.1016/j.neulet.2008.03.014

Puskás, 2010, Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice, Peptides, 31, 1589, 10.1016/j.peptides.2010.04.020

Bochorishvili, 2014, The orexinergic neurons receive synaptic input from C1 cells in rats, J. Comp. Neurol., 522, 3834, 10.1002/cne.23643

Li, 2013, Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats, J. Physiol., 591, 4237, 10.1113/jphysiol.2013.256271

Patel, 2018, Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection, Clin. Sci. (Lond.), 132, 2547, 10.1042/CS20180150

Bose, 2007, Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway, Cardiovasc. Drugs Ther., 21, 253, 10.1007/s10557-007-6030-6

Bopassa, 2010, A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury, Am. J. Physiol. Heart Circ. Physiol., 298, H16, 10.1152/ajpheart.00588.2009

Carrive, 2017, Orexin and central modulation of cardiovascular and respiratory function, Curr. Top. Behav. Neurosci., 33, 157, 10.1007/7854_2016_46

Huang, 2010, Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors, J. Pharmacol. Exp. Ther., 334, 522, 10.1124/jpet.110.167791

Thông tin
Thông tin xuất bản

Clinical Science

Tập 133 Số 7

853-857

Thông tin tác giả